Through our pan-cancer analysis, we found that CEP55 was significantly correlated with MDSCs and Th1 cells in most cancers and positively correlated with the expression of checkpoints, such as PD1, CTLA4, LAG3, and TIGIT in certain cancer types. This evidence concerns the gene CEP55 and cancer.